India’s medicine regulator is criticised for quality checking only cough medicines destined for export

India’s system for regulating medicines has been questioned after an investigation found that more than 100 cough syrups made for the export market failed quality tests.Specialists have said that the Central Drugs Standard Control Organization (CDSCO), the national regulatory body for pharmaceuticals that conducted the investigation, lacks the necessary oversight to ensure that medicines manufactured in India are safe.The comments follow a report from CDSCO shared with the media on 4 December on the results of tests conducted on more than 2000 cough syrups. Of these, 128 syrups manufactured by 54 companies, which were meant for the export market, were found to have problems with quality.1In June this year India’s director general of foreign trade mandated that cough syrups meant for export must undergo tests at a government laboratory and must be authorised with a certificate of analysis before they can leave the country.4 However, Dinesh Thakur, a public health…
Read Original Article: India’s medicine regulator is criticised for quality checking only cough medicines destined for export »